Validation of highly selective Sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis

Stephanie Schwalm, Sandra Beyer, Redona Hafizi, Sandra Traufmann, Gerd Geisslinger, David R. Adams, Susan Pyne, Nigel Pyne, Liliana Schaefer, Andrea Huwiler, Josef Pfeilschifter

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)
31 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Validation of highly selective Sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosis'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry